Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Fosfomycin Disodium
2. 26016-99-9
3. Phosphonemycin
4. Fosfomycin Disodium Salt
5. Phosphomycin Disodium Salt
6. Veramina
7. Disodium Phosphonomycin
8. Disodium (1r,2s)-(1,2-epoxypropyl)phosphonate
9. Fosfomycin Sodium [jan]
10. Disodium Fosfomycin
11. Priomicina
12. Fosfomycin Sodium Salt
13. 97mmo19fno
14. Fosfocina Disodium Salt
15. Phosphonomycin Disodium Salt
16. Sodium Fosfomycin
17. Phosphonomycin Sodium
18. Phosphonic Acid, [(2r,3s)-3-methyloxiranyl]-, Disodium Salt
19. Disodium [(2r,3s)-3-methyloxiran-2-yl]phosphonate
20. Fom-na
21. Mk 955
22. Fosfocin
23. Forocyle S
24. Fosmicin S
25. Nsc-136017
26. Einecs 247-409-2
27. Unii-97mmo19fno
28. Nsc 136017
29. Levo-phosphonomycin Disodium Salt
30. (?)-fosfomycin
31. Fosmicin S (tn)
32. Phosphonemycin Disodium
33. (2r-cis)-(3-methyloxiranyl)phosphonic Acid Disodium Salt
34. (1r,2s)(-)-(1,2-epoxypropyl)phosphonic Acid Disodium Salt
35. Phosphonic Acid, (3-methyloxiranyl)-, Disodium Salt, (2r-cis)-
36. Fosfomycin Sodium (jp17)
37. Schembl9634056
38. Chembl1256140
39. Fosfomycin Sodium [mart.]
40. Dtxsid401017220
41. Fosfomycin Sodium [who-dd]
42. Mfcd00056853
43. Phosphonic Acid, (1,2-epoxypropyl)-, Disodium Salt (1r,2s) (-)-
44. Akos015963278
45. Ccg-266439
46. Fosfomycin Sodium [ep Impurity]
47. Fosfomycin Sodium [ep Monograph]
48. 25162-71-4
49. As-11021
50. As-13713
51. F0889
52. Disodium (1r,2s)-1,2-epoxypropylphosphonate
53. D02188
54. Sodium ((2r,3s)-3-methyloxiran-2-yl)phosphonate
55. Fosfomycin Sodium, Vetranal(tm), Analytical Standard
56. Q27272022
57. (1r,2s)-1,2-epoxypropylphosphonic Acid Disodium Salt
58. Disodium (2r,3s)-3-methyloxiran-2-ylphosphonate
59. Phosphomycin Disodium Salt, Antibacterial Mura Inhibitor
60. Z1583387379
61. Phosphonic Acid,(3-methyloxiranyl)-,disodium Salt,cis-(+-)-
62. Disodium;[(2r,3s)-3-methyloxiran-2-yl]-dioxido-oxo-lambda5-phosphane
Molecular Weight | 182.02 g/mol |
---|---|
Molecular Formula | C3H5Na2O4P |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 181.97208420 g/mol |
Monoisotopic Mass | 181.97208420 g/mol |
Topological Polar Surface Area | 75.7 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 127 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Fosfomycin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosfomycin Sodium, including repackagers and relabelers. The FDA regulates Fosfomycin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosfomycin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosfomycin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosfomycin Sodium supplier is an individual or a company that provides Fosfomycin Sodium active pharmaceutical ingredient (API) or Fosfomycin Sodium finished formulations upon request. The Fosfomycin Sodium suppliers may include Fosfomycin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Fosfomycin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fosfomycin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Fosfomycin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Fosfomycin Sodium DMFs exist exist since differing nations have different regulations, such as Fosfomycin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fosfomycin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Fosfomycin Sodium USDMF includes data on Fosfomycin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fosfomycin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fosfomycin Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fosfomycin Sodium Drug Master File in Japan (Fosfomycin Sodium JDMF) empowers Fosfomycin Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fosfomycin Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Fosfomycin Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fosfomycin Sodium suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosfomycin Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosfomycin Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosfomycin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosfomycin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosfomycin Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosfomycin Sodium suppliers with NDC on PharmaCompass.
Fosfomycin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosfomycin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosfomycin Sodium GMP manufacturer or Fosfomycin Sodium GMP API supplier for your needs.
A Fosfomycin Sodium CoA (Certificate of Analysis) is a formal document that attests to Fosfomycin Sodium's compliance with Fosfomycin Sodium specifications and serves as a tool for batch-level quality control.
Fosfomycin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Fosfomycin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosfomycin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosfomycin Sodium EP), Fosfomycin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosfomycin Sodium USP).
LOOKING FOR A SUPPLIER?